UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | September 22, 2022 5:00 P.M. |
Form: | S-1 |
CIK: | 0001736243 |
Company Name: | Acurx Pharmaceuticals, Inc. |
File Number: | 333-267412 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Acurx Pharmaceuticals Inc. published this content on 22 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 September 2022 11:10:15 UTC.